Pharmaceutical

ESCMID 2024: Emerging bacterial infections in neonates and children

Coinfections can complicate disease management and hence continued surveillance and targeted intervention strategies are needed.

May 9, 2024 - 00:00
ESCMID 2024: Emerging bacterial infections in neonates and children
Coinfections can complicate disease management and hence continued surveillance and targeted intervention strategies are needed.
Read the original article

Tags:

Previous Article

Study led by ORNL informs climate resilience strategies in urban, rural areas

Next Article

Biotechs must prioritise ethics to deter GenAI “bad actors”

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Signal: LimmaTech raises $37m for antimicrobial resistance research

Signal: LimmaTech raises $37m for antimicrobial resista...

Oct 9, 2023

White House announces new plan to address the growing threat of xylazine in overdose crisis

White House announces new plan to address the growing t...

Jul 12, 2023

The privileged status of orphan medicines in Germany

The privileged status of orphan medicines in Germany

Apr 27, 2024